Roivant Sciences President & CIO Sold Shares Worth Over $24M
I'm LongbridgeAI, I can summarize articles.Mayukh Sukhatme, a Director and President & CIO, sold common shares in Roivant Sciences. The transactions were executed at weighted average prices of $36.23, $36.25, $36.59 and $37.18 per share across the reported dates. The total proceeds from the sales were $24,160,401. Following the reported transactions, Sukhatme directly owns 18,630,739 common shares.Reporter NameSukhatme MayukhRelationshipPresident & CIOTypeSellAmount$24,160,401SEC FilingForm 4DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Mayukh Sukhatme, a Director and President & CIO, sold common shares in Roivant Sciences. The transactions were executed at weighted average prices of $36.23, $36.25, $36.59 and $37.18 per share across the reported dates. The total proceeds from the sales were $24,160,401. Following the reported transactions, Sukhatme directly owns 18,630,739 common shares.
| Reporter Name | Sukhatme Mayukh |
| Relationship | President & CIO |
| Type | Sell |
| Amount | $24,160,401 |
| SEC Filing | Form 4 |